Načítá se...
Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
Dyslipidemia is a major risk factor for cardiovascular disease (CVD), which is the leading cause of morbidity and mortality in type 2 diabetes (T2DM). Statins have played a crucial role in its management, but residual risk remains since many patients cannot achieve their desired low-density lipoprot...
Uloženo v:
| Vydáno v: | Diseases |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6023493/ https://ncbi.nlm.nih.gov/pubmed/29794992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases6020044 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|